Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Callard, Rebecca"'
Autor:
Catterson, James H, Khericha, Mobina, Dyson, Miranda C, Vincent, Alec J, Callard, Rebecca, Haveron, Steven M, Rajasingam, Arjunan, Ahmad, Mumtaz, Partridge, Linda
Publikováno v:
Curr Biol
Intermittent fasting (IF) can improve function and health during aging in laboratory model organisms, but the mechanisms at work await elucidation. We subjected fruit flies (Drosophila melanogaster) to varying degrees of IF and found that just one mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5b81824687f9e76975821075f694e5ad
https://hdl.handle.net/21.11116/0000-0004-71FD-0
https://hdl.handle.net/21.11116/0000-0004-71FD-0
Autor:
Kerr, Fiona, Sofola-Adesakin, Oyinkan, Ivanov, Dobril K., Gatliff, Jemma, Gomez Perez-Nievas, Beatriz, Bertrand, Hélène C., Martinez, Pedro, Callard, Rebecca, Snoeren, Inge, Cochemé, Helena M., Adcott, Jennifer, Khericha, Mobina, Castillo-Quan, Jorge Iván, Wells, Geoffrey, Noble, Wendy, Thornton, Janet, Partridge, Linda
Publikováno v:
PLoS Genetics
PLOS Genetics
PLOS Genetics
Nrf2, a transcriptional activator of cell protection genes, is an attractive therapeutic target for the prevention of neurodegenerative diseases, including Alzheimer’s disease (AD). Current Nrf2 activators, however, may exert toxicity and pathway o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1d24833572d663fd0bbdaf0472da06ae
Autor:
Kerr, Fiona, Sofola-Adesakin, Oyinkan, Ivanov, Dobril, Gatliff, Jemma, Gomez Perez-Nievas, Beatriz, Bertrand, Helene, Martinez, Pedro, Callard, Rebecca, Snoeren, Inge, Cocheme, Helena, Adcott, Jennifer, Khericha, Mobina, Castillo-Quan, Jorge, Noble, Wendy, Wells, Geoffrey, Thornton, Janet, Partridge, Linda
Publikováno v:
Kerr, F, Sofola-Adesakin, O, Ivanov, D, Gatliff, J, Gomez Perez-Nievas, B, Bertrand, H, Martinez, P, Callard, R, Snoeren, I, Cocheme, H, Adcott, J, Khericha, M, Castillo-Quan, J, Noble, W, Wells, G, Thornton, J & Partridge, L 2017, ' Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease : Keap1 as a therapeutic target for Alzheimer's Disease ', PL o S Genetics, vol. 13, no. 3, e1006593 . https://doi.org/10.1371/journal.pgen.1006593
Nrf2, a transcriptional activator of cell protection genes, is an attractive therapeutic target for the prevention of neurodegenerative diseases, including Alzheimer’s disease (AD). Current Nrf2 activators, however, may exert toxicity and pathway o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2761::2e5da4df1a83fffbc938799806c1ca76
https://kclpure.kcl.ac.uk/en/publications/eb48b61d-983a-49a8-8967-3c6cdbce8e2e
https://kclpure.kcl.ac.uk/en/publications/eb48b61d-983a-49a8-8967-3c6cdbce8e2e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.